Diabetic retinopathy
128 results
1 - 100
Diabetic retinopathy 
Fenofibrate for diabetic retinopathy- Proliferative diabetic retinopathy - Image
- Blood pressure control for diabetic retinopathy
- Aspirin in diabetic retinopathy
- Diabetic retinopathy during pregancy - Image
- Laser photocoagulation for proliferative diabetic retinopathy
- Severe nonproliferative diabetic retinopathy - Image
- Single herbal medicine for diabetic retinopathy
- Impact of diabetic retinopathy screening
- Diabetic retinopathy with neovascularisation - Image
- Pentoxifylline for diabetic retinopathy: Cochrane systematic review
- Laser photocoagulation for diabetic retinopathy
- Typical findings of diabetic retinopathy - Image
- Diabetic retinopathy: neovascularisation and a microinfarction - Image
- Screening and monitoring tests for diabetic retinopathy
- Pain control during panretinal photocoagulation for diabetic retinopathy
- Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
- Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy: Cochrane systematic review
- Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
- Bevacizumab to prevent haemorrhage after vitrectomy for proliferative diabetic retinopathy
- Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
- Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy
- Different lasers and techniques for proliferative diabetic retinopathy: Cochrane systematic review
- Anti‐vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy
- Interventions to increase attendance for diabetic retinopathy screening: Cochrane systematic review
- Comprehensive treatment and follow-up of type 2 diabetes
- Central retinal artery occlusion
Tight blood sugar control or fibrates prevent retinopathy progression but not visual loss (ACCORD)- Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema: Cochrane systematic review
- Vitreous haemorrhage (VH)
- Glycaemic control for slowing the progression of microvascular complications in diabetes mellitus
- Fibrates for primary prevention of cardiovascular disease events
- Monotherapy laser photocoagulation for diabetic macular oedema
- Oral antidiabetic drugs and GLP-1 analogues
- Association of glycaemic control and complications of type 2 diabetes
- Fenofibrate reduces laser photocoagulation (FIELD)
- Impaired vision
- Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema
- Eye symptoms and signs of systemic diseases
- Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
- Monotherapy laser photocoagulation for diabetic macular oedema
- Age-related macular degeneration (AMD)
- Diabetic kidney disease (diabetic nephropathy)
- Blindness and visual impairment
- Retinal venous thrombosis
- Orbital radiotherapy for adult thyroid eye disease: Cochrane systematic review
- Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus: Cochrane systematic review
- Retinal detachment
- Follow-up of type 1 diabetes
- Enhanced glucose control for preventing and treating diabetic neuropathy in type 1 diabetes
- Dipyridamole for preventing stroke and other vascular events in patients with vascular disease: Cochrane systematic review
- Anti‐vascular endothelial growth factor for neovascular glaucoma